NASH Clinical Trials in California - Advancing NASH Care and Shaping the Future of Treatment
In the pursuit of medical breakthroughs for Nonalcoholic Steatohepatitis (NASH), FOMAT Medical Research stands at the forefront, dedicated to the advancement of research and discovery of effective treatments. Our unwavering commitment to NASH clinical trials aims to unveil innovative solutions to combat this silent yet impactful liver disease, promising a brighter future for patients around the globe.
Understanding Nonalcoholic Steatohepatitis (NASH)
NASH, a severe form of nonalcoholic fatty liver disease (NAFLD), poses a significant threat to individuals' health, affecting millions worldwide. This condition, characterized by liver inflammation and damage due to fat buildup, can lead to more severe complications such as cirrhosis and liver failure. At FOMAT Medical Research, we emphasize the critical need for comprehensive research in diagnosing, treating, and preventing NASH, acknowledging its profound impact on both individuals and communities.
Why Clinical Trials Are Crucial for NASH Research
Clinical trials are the cornerstone of progress in combating NASH. These studies are pivotal in addressing the current challenges in NASH diagnosis and management, including the development of non-invasive diagnostic tools, expanding treatment options, and understanding the variability in disease progression. Through clinical trials, FOMAT aims to improve patient outcomes and offer hope to those battling this condition.
Symptoms and Progression of NASH
Recognizing the symptoms and understanding the progression of NASH is vital for early intervention. The journey from NAFLD to NASH and its severe complications underscores the importance of symptom awareness and disease monitoring. Our research focuses on elucidating this progression to foster prompt and effective treatment strategies.
Causes and Risk Factors
Several factors play a role in the development of NASH, such as obesity, type 2 diabetes, insulin resistance, genetics, and lifestyle habits. FOMAT emphasizes that understanding NASH's complex causes is key to developing comprehensive research and treatment plans.
Complications of NASH
The potential complications of NASH, such as cirrhosis, liver failure, and hepatocellular carcinoma, emphasize the need for early detection and intervention. Our research endeavors aim to mitigate these risks, improving patient prognosis and reducing healthcare costs.
What are Clinical Trials?
Clinical trials are research studies conducted with human participants to assess the efficacy and safety of various interventions, including medications, surgical procedures, or lifestyle changes. These studies are crucial for determining whether new therapies are safe and effective. In the context of Non-Alcoholic Steatohepatitis (NASH), clinical trials investigate innovative treatment methods, diagnostic tools, and ways to comprehend the disease better. Participation in a clinical trial provides an opportunity to contribute to medical science and potentially access new treatments before they become broadly accessible.
Why Participate in Clinical Trials?
Participating in clinical trials offers multiple advantages, especially in gaining access to new treatments for Non-Alcoholic Steatohepatitis (NASH) not yet available to the general public. This access can be pivotal, particularly when existing treatments have not been effective, potentially leading to personal health benefits. Additionally, participants provide essential data that aids researchers in understanding NASH better, thereby contributing to the progression of treatment and care methods for the disease. Engaging in a clinical trial allows individuals to play a crucial role in the development of novel medical interventions that may enhance the quality of life for future patients. Furthermore, clinical trials typically ensure participants receive meticulous monitoring from healthcare professionals, adding an extra level of medical supervision.
Our Active Studies
-
NASH Trial
NASH, often a silent liver condition, typically remains undetected until it becomes advanced. It begins with an accumulation of fat in the liver and can progress to significant liver injury. Taking early measures is crucial to curb its severity.
Read more
Criteria & Qualifications: • Participants need to be aged 18 or older.
• Must have a diagnosis of Fatty Liver Disease.
Compensation: Contact us for more information -
NASH Study
NASH is a liver disease with inflammation and damage from fat buildup. If you have NASH, consider participating in our study to help find new treatments.
Read more
Criteria & Qualifications: • Must be 18 years or older.
• Diagnosed with Ulcerative Colitis.
• Is willing to provide medical records.
Compensation: Contact us for more information -
NASH
Coming Soon! NASH is a quiet liver disease that often shows no symptoms until it's severe. It starts with extra liver fat and can lead to serious liver damage. Early action is key to preventing it from getting worse.
Read more
Criteria & Qualifications: • Must be over 18 years old.
• Diagnosed with Fatty Liver Disease.
Compensation: Contact us for more information -
NASH Study
Nonalcoholic fatty liver disease (NAFLD) is a condition where fat accumulates in the liver. NASH, the more severe form, causes swelling and damage to the liver. Currently, there is no existing treatment for NASH.
Read more
Criteria & Qualifications: • Is at least 18 years of age or older.
• Inflammation and liver damage, also known as Nonalcoholic steatohepatitis (NASH).
• Must be weight stable for 6 months.
Compensation: Up to $3,000.
Who is FOMAT Medical Research?
FOMAT Medical Research is California's largest research site network, dedicated to advancing clinical research and improving patient outcomes. With an extensive network of research sites and a relentless commitment to innovating healthcare through diversity, FOMAT Medical Research collaborates with industry Sponsors and CROs to accelerate the development of groundbreaking therapies across multiple therapeutic areas. FOMAT is a founding member of hyperCORE International, a super network of fully professionalized research site organizations.
FOMAT's Commitment to NASH Research
FOMAT Medical Research is renowned for its expertise in conducting NASH-related clinical trials. Our commitment to advancing knowledge and discovering new treatments for NASH is unwavering, with several ongoing and completed studies under our belt.
Meet Our Experts
